Cronos Group Inc vs Liberty Global Ltd Class C — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.06B). The key difference: Liberty Global Ltd Class C is far larger — about 2.6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Liberty Global Ltd Class C for 21 Days on average.
| CRON | LBTYK | |
|---|---|---|
Market Cap | $1.18B | $3.06B |
Volume | 968,037 | 2,508,956 |
Sector | Health | Media |
52-Week High | $3.55 | $12.67 |
52-Week Low | $2.30 | $8.75 |
Typical Hold Time | 22 Days | 21 Days |
Enterprise Value | $387.62M | $9.72B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
Liberty Global (LBTYK) trades at $8.92, down 0.28% on the day and near 52-week lows. The stock shows bearish technical signals with mixed quarterly earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Despite negative profitability metrics (-62.14% net margin), the company maintains strong operating cash flow of $1.21B and trades at discounted valuations with P/S of 0.61 and P/B of 0.32. Recent developments include the VodafoneZiggo acquisition completion and AI partnership with Sierra.
The investment case hinges on the 2027 Ziggo Group spin-off unlocking value, supported by analyst consensus price target of $12.67 (42% upside). However, persistent net losses and bearish technical momentum present significant risks. The stock offers speculative appeal for investors betting on management's restructuring success, but requires careful risk management given ongoing profitability challenges.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →